Testicular dysgenesis syndrome: possible role of endocrine disrupters
- 1 March 2006
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 20 (1), 77-90
- https://doi.org/10.1016/j.beem.2005.09.004
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Concentrations of polychlorinated biphenyls in blood and the risk for testicular cancerInternational Journal of Andrology, 2004
- Male reproductive disorders and the role of endocrine disruption: Advances in understanding and identification of areas for future researchPure and Applied Chemistry, 2003
- HYPOSPADIAS AND URETHRAL DEVELOPMENTJournal of Urology, 2000
- Stat Bite: U.S. Incidence of Testicular CancerJNCI Journal of the National Cancer Institute, 1999
- RISK FACTORS FOR CRYPTORCHIDISM AND HYPOSPADIASJournal of Urology, 1999
- Semen quality of Finnish men.BMJ, 1993
- Changes in testicular cancer in ScotlandEuropean Journal of Cancer and Clinical Oncology, 1987
- Cryptorchidism: an apparent substantial increase since 1960. John Radcliffe Hospital Cryptorchidism Study Group.BMJ, 1986
- TRENDS IN CONGENITAL MALFORMATIONS OF EXTERNAL GENITALIAThe Lancet, 1985
- Males exposed in utero to diethylstilbestrolPublished by American Medical Association (AMA) ,1984